Introduction to the Theme "Development of New Drugs: Moving from the Bench to Bedside and Improved Patient Care".

Journal: Annual review of pharmacology and toxicology
Published Date:

Abstract

Investigations in pharmacology and toxicology range from molecular studies to clinical care. Studies in basic and clinical pharmacology and in preclinical and clinical toxicology are all essential in bringing new knowledge and new drugs into clinical use. The 30 reviews in Volume 63 of the explore topics across this spectrum. Examples include "Zebrafish as a Mainstream Model for In Vivo Systems Pharmacology and Toxicology" and "Artificial Intelligence and Machine Learning for Lead-to-Candidate Decision-Making and Beyond." Other reviews discuss components important for drug discovery and development and the use of pharmaceuticals in a variety of diseases. Air pollution continues to increase globally; accordingly, "Air Pollution-Related Neurotoxicity Across the Life Span" is a timely and forward-thinking review. Volume 63 also explores the use of contemporary technologies such as electronic health records, pharmacogenetics, and new drug delivery systems that help enhance and improve the utility of new therapies.

Authors

  • Terrence F Blaschke
    Stanford University School of Medicine, Stanford, California, USA; email: blaschke@stanford.edu.
  • Paul A Insel
    Departments of Pharmacology and Medicine, University of California, San Diego, La Jolla, California, USA.
  • Susan G Amara
    Laboratory of Molecular and Cellular Neurobiology, National Institute on Mental Health, NIH, Bethesda, MD 20892, USA.
  • Urs A Meyer
    Biozentrum, University of Basel, Basel, Switzerland.